Recognify Life Sciences, a company Atai Life Sciences is a strategic investor in, said its trial for a cognitive decline treatment missed its primary endpoint. Atai shares fell 13% to $3.08 in ...

Italian oil major Eni raised some 2025 growth projections and said it would buy back up to roughly $1.76 billion of shares over the year despite commodity and currency headwinds. Write to Rob Curran ...

Find insight on EFG International, Deutsche Bank and more in the latest Market Talks covering Financial Services.

Dow's 17% plunge and 50% dividend cut reflect deep cyclical challenges, weak margins, and heavy debt. Click here to find out ...

Bristol Myers Squibb's chief medical officer, Samit Hirawat, is leaving the drugmaker to pursue new professional opportunities.

The S&P 500 and Nasdaq Composite ended at record highs on Thursday (July 24), supported by stronger-than-expected earnings ...

The technology giant turned heads on Wall Street when it announced Wednesday that it was boosting its capital-expenditure forecast for the year to $85 billion from $75 billion. The Google parent ...

U.S. stocks traded mixed this morning, with the Dow Jones index falling more than 300 points on Thursday. Following the ...

DIAX writes options on a portfolio of constituents of the Dow Jones index and makes it possible to collect a higher yield than average. See why the Fund is a Buy.

Northrop Grumman is positioned to capitalize on international demand, in the Middle East and Europe, fueled by regional ...

Find insight on GM, Stellantis and more in the latest Market Talks covering Auto and Transport.

Whereas the average S&P 500 bear market has resolved in 286 calendar days (about 9.5 months) over a nearly 94-year period, ...